Banzai International, Inc. short interest in 2022
In 2022, Banzai International, Inc.'s disclosed short interest ran from 0.14% of shares outstanding on 14 Jan 2022 to 0.03% on 30 Dec 2022, a change of -0.11 percentage points. The year's high was 0.15% on 31 Jan 2022 and its low 0.02% on 31 May 2022, averaging 0.07% across 22 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 18.79 days on 30 Nov 2022. Full history: Banzai International, Inc..
Cite this page
By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2022 in figures
- Start of year
- 0.14% (14 Jan 2022)
- End of year
- 0.03% (30 Dec 2022)
- Change
- -0.11 pp
- High
- 0.15% (31 Jan 2022)
- Low
- 0.02% (31 May 2022)
- Average
- 0.07%
- Highest days to cover
- 18.79 (30 Nov 2022)
- SEC filings marked
- 4
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Jan 2022 | 0.14% | 3.21 | |
| 31 Jan 2022 | 0.15% | 7.48 | |
| 15 Feb 2022 | 0.15% | 2.40 | |
| 28 Feb 2022 | 0.13% | 1.00 | |
| 15 Mar 2022 | 0.13% | 1.00 | |
| 31 Mar 2022 | 0.13% | 1.00 | |
| 14 Apr 2022 | 0.13% | 1.97 | 10-K filed |
| 13 May 2022 | 0.05% | 1.00 | |
| 31 May 2022 | 0.02% | 1.00 | 10-Q filed |
| 15 Jun 2022 | 0.02% | 1.00 | |
| 30 Jun 2022 | 0.03% | 1.10 | |
| 15 Jul 2022 | 0.03% | 1.00 | |
| 29 Jul 2022 | 0.02% | 1.00 | |
| 15 Aug 2022 | 0.02% | 1.31 | 10-Q filed |
| 31 Aug 2022 | 0.02% | 1.00 | |
| 30 Sep 2022 | 0.02% | 1.00 | |
| 14 Oct 2022 | 0.06% | 1.00 | |
| 31 Oct 2022 | 0.03% | 1.00 | |
| 15 Nov 2022 | 0.05% | 1.00 | 10-Q filed |
| 30 Nov 2022 | 0.05% | 18.79 | |
| 15 Dec 2022 | 0.04% | 1.00 | |
| 30 Dec 2022 | 0.03% | 1.00 |
See also: Banzai International, Inc.'s full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.